0001055726-21-000011.txt : 20210226 0001055726-21-000011.hdr.sgml : 20210226 20210226190505 ACCESSION NUMBER: 0001055726-21-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210226 FILED AS OF DATE: 20210226 DATE AS OF CHANGE: 20210226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shea Jacqueline Elizabeth CENTRAL INDEX KEY: 0001771498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 21692744 MAIL ADDRESS: STREET 1: C/O INOVIO PHARMACEUTICALS, INC. STREET 2: 660 W. GERMANTOWN PIKE, SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wf-form4_161438428463289.xml FORM 4 X0306 4 2021-02-26 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001771498 Shea Jacqueline Elizabeth 660 W. GERMANTOWN PIKE PLYMOUTH MEETING PA 19462 0 1 0 0 Chief Operating Officer Common Stock Option 11.1 2021-02-26 4 A 0 104833 0 A 2021-02-26 2031-02-26 Common Stock 104833.0 104833 D Restricted Stock Unit 2021-02-26 4 A 0 67633 0 A Common Stock 67633.0 67633 D The vesting schedule for the 104,833 options is as follows: 26,208 shares vested on February 26, 2021; 26,208 shares will vest on February 26, 2022; 26,208 shares will vest on February 26, 2023; 26,209 shares will vest on February 26, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. /s/ Jacqueline E. Shea 2021-02-26